A case of hydrops fetalis, probably due to antibodies directed against antigenic determinants of GP.Mur (Miltenberger class III) cells

Immunohematology

Volumn 12, Issue 3, 1996, Pages 115-118

  Lin, C K ^a   Mak, K H ^a   Yuen, C M Y ^a   Chan, N K ^a   Liu, H W ^a   Cheng, G ^b  

^a Hong Kong Red Cross Blood Transfusion Service   (Hong Kong)

^b QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROCYTE ANTIGEN;

ANTIBODY DETECTION; ARTICLE; CASE REPORT; FETUS; FETUS HYDROPS; HETEROZYGOSITY; HUMAN; IMMUNOPATHOGENESIS; PRIORITY JOURNAL;

EID: 0029808208     PISSN: 0894203X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Huang CH, Johe KK, Seifter S, Blumenfeld OO. Biochemistry and molecular biology of MNSs blood group antigens. Bailliere's Clinical Haematology 1991;4:821-48.
2. Huang CH, Blumenfeld OO. Molecular genetics of human crythrocyte MiIII and MiVI glycophorins. Use of pseudoexon in construction of two delta-alpha-delta hybrid genes resulting in antigenic diversification. J Biol Chem 1991;266:7238-55.
3. Dahr W. Miltenberger subsystem of the MNSs blood group system, review and outlook. Vox Sang 1992;62:129-35.
4. Cleghorn TE. The occurrence of certain rare blood group factors in Britain, 1961. M.D. thesis. University of Sheffield.
5. Chandanayingyong D, Pejrachandra S. Studies on the Miltenberger complex frequency in Thailand and family studies. Vox Sang 1975b;28:152-5.
6. Broadberry RE, Lin M. The incidence and significance of anti-"Mia" in Taiwan. Transfusion 1994;34:349-52.
7. Poole J.,King MJ, Mak KH, Liew YW, Leong S, Chua KM. The MiIII phenotype among Chinese donors in Hong Kong: immunochemical and serological studies. Transfus Med 1991;1:169-75.
8. Issitt PD. Applied blood group serology. 3rd ed. Miami, FL: Montgomery Scientific Publications. 1985:350-1.
9. Race RR, Sanger R. Blood groups in man. 6th ed. Oxford: Blackwell Scientific Publications, 1975:126.
10. Taylor AM, Knighton GJ. A case of severe hemolytic disease of the newborn due to anti-Verweyst. Transfusion 1982:165-6.
11. Lin M, Broadberry RE. An intravascular hemolytic transfusion reaction due to anti-"Mia" in Taiwan. Vox Sang 1994;67:320.
12. Cheng G, Hui CH, Lam CK, et al. Haemolytic transfusion reactions due to Mi antibodies, need to include MiIII positive cells in pre-transfusion antibody screening in Hong Kong. Clin Lab Haem 1995;17:183-4.
13. Walker RH. editor-in-chief. Technical manual, 11th ed. Bethesda, MO: American Association of Blood Banks, 1993
14. Olson PR, Weiblen BJ, O'Leary JJ, Moscowitz AJ, McCullough J. A simple technique for the inactivation of IgM antibodies using dithiothreitol. Vox Sang 1976;30:149-59
15. Marsh WL. Scoring of hemagglutination reactions. Transfusion 1972;12:352-3.
16. King MJ, Poole J, Anstee DJ. An application of immunoblotting in the classification of the Miltenberger series of blood group antigens. Transfusion 1989;29:106-12.
17. Nance SJ, Arndt P, Garratty G. Predicting the clinical significance of red cell alloantibodies using a monocyte monolayer assay. Transfusion 1987;27:449-52.
18. Schanfield MS, Schoeppner SL, Stevens JO. New approaches to detecting clinically significant antibodies in the laboratory. In: Sandler SG, Nusbacher J, Schanfield MS, eds. Immunobiology of erythrocytes. New York, NY: Alan R Liss, 1980:305-23.
19. Hadley AG, Poole GD, Fraser ID. Predicting the severity of haemolytic disease of the newborn: prospective evaluation of the chemiluminescence test (letter). Vox Sang 1992;63:291-2.
20. Lin CK, Mak KH, Szeto SC, et al. First case of hemolytic disease of the newborn due to anti-Mur in Hong Kong (in press, Clin Lab Haematol).
21. Feng CS. The clinical significance of anti-"Mia" (letter). Transfusion 1994;11:1014.